Oncology

Lung Cancer Treatment Varies by Insurance Type

Patients with nonmetastatic small-cell lung cancer are less likely to receive both chemotherapy and thoracic radiation — the standard of care for initial management of the disease — if they rely on federal programs such as Medicare or Medicaid than if they have private insurance, according to...


Cancer Drugs: Cost vs. Affordability

Reduced prices for cancer drugs in middle-income countries do not ensure the drugs are as affordable to patients in those nations as they are to patients in high-income nations, according to a study published in Oncotarget.

Researchers assessed affordability in high-income...


Biomarker May Shed Light on Prostate Cancer’s Aggressiveness

A 70-gene-expression metastatic assay biomarker could change how physicians determine treatment plans for patients with prostate cancer.


Bunches of Promise: Study Shows Grape Compounds May Prevent Colorectal Cancer

A combination of grape seed extract (GSE) and the grape compound resveratrol suppresses colon cancer stem cells with efficacy similar to that of a chemopreventive drug, but without the latter’s adverse effects, according to Pennsylvania State University researchers. They believe their findings could open the door to novel therapies to prevent colorectal cancer.


That's News

Extended Antibiotic Use May Boost Risk of Colorectal Cancer Precursor

Long use of antibiotics is associated with higher risk of colorectal adenoma, according to an observational study in Gut. Adenomas are precursors for most colorectal cancers.

A multi-institutional team of...


A Fuller Picture: The Transformative Potential of Total-body PET

PET — one of the most important tools in clinicians’ armamentarium for cancer diagnosis, staging and therapy evaluation — has a significant limitation: It can scan only a portion of the body at a time. That may change soon, with wide implications for research and clinical practice.


Full-court Oncologic Press

The challenges of cancer treatment remain formidable, particularly as the number of cases grows along with the aging U.S. population. However, scientists are exploring new avenues of research to extend life.


Building on the Promise of Radioembolization with Yttrium-90

Yttrium-90 (Y-90) has long been used to treat liver cancer. Researchers are exploring its potential to treat diseases in other sites, but a number of obstacles have made progress halting.


When Tests Collide: Perspectives on Liquid vs. Tissue Biopsies

As liquid biopsies inch closer to becoming a standard of care, questions about their efficacy, use and role in cancer diagnosis and treatment abound. Discordant research findings between liquid and tissue biopsies only add to the confusion.


That's News

Direct Communication Linked to Higher Screening Rate

When women who are at high risk for breast cancer and have undergone mammography get a letter describing options for further imaging with contrast-enhanced MRI of the breast, they are more apt to return for follow-up screening,...